Merna Akram Estreed

Merna Akram Estreed

Auto-generated profile, based on publicly available information

Merna Akram Estreed

Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
Krishan SarnaKrishan Sarna
Krishan Sarna
MEMerna A. Estreed
Merna A. Estreed
KSKhushboo J. Sonigra
Khushboo J. Sonigra
TAThomas Amuti
Thomas Amuti
FOFlorence Opondo
Florence Opondo
WNWei C. Ngeow
Wei C. Ngeow
Study Design: Descriptive cross-sectional. Objective: To determine the morphology and morphometry of the nasopalatine canal (NPC) and incisive foramen (IF) in an African population. Methods: Measurements of the NPC and the IF were carried out on 150 Cone-Beam computed tomography (CBCT) scans. The maxillary bone thickness anterior to the NPC was measured at 3 levels. Independent t-test and Chi-square test were performed to determine the presence of sexual dimorphism. Results: The presence of one Stenson’s foramen was most prevalent. The mean length of NPC was 13.21 ± 3.25 mm with significantly longer canals in males. The most prevalent shape of NPC was cylindrical in sagittal view and a single canal in coronal view. The mean angulation of NPC was 118.42° to the horizontal plane. The average dimensions of the IF were 3.53 mm and 3.07 mm in the anteroposterior and mediolateral diameter, respectively, while the most common shape was round. The anterior maxillary bone was thicker in males and generally reduced in thickness from the anterior nasal spine superiorly towards the alveolar crest inferiorly. Conclusion: This study highlights the anatomical characteristics of the NPC and IF, with significant sexual dimorphism observed regarding the number of Stenson’s foramina, length of NPC, shapes of the NPC and IF, as well as alveolar bone thickness anterior to NPC.

27 May 2026 in Malaria Journal
Verified
Journal Article
Open access
KNKhulud Nurani
Khulud Nurani
NKNajib Kadernani
Najib Kadernani
EKEmmanuel Korir
Emmanuel Korir
MEMerna Akram Estreed
Merna Akram Estreed
ADArkadeep Dhali
Arkadeep Dhali
Moses Muia MasikaMoses Muia Masika
Moses Muia Masika
Background: Malaria remains a major public health burden in Africa, particularly among children under five years of age. By consolidating findings across randomized controlled trials on the RTS,S and R21 malaria vaccines, this study seeks to provide an evidence based guide. Methods: We conducted a systematic review and meta-analysis of studies of randomized controlled trials evaluating the RTS,S and R21 malaria vaccines in African children under five. Data sources included PubMed, Scopus, and Embase. Primary outcomes were the vaccine efficacies against first/only episodes of malaria, multiple episodes and severe malaria; and the incidence of severe adverse events following vaccination. Pooled effect estimates were calculated using random-effects models. Results: Eleven studies enrolling 27,178 participants (RTS,S: 21,589; R21: 5589) were included. For RTS,S, pooled efficacy against first clinical malaria episode was 32% (HR 0.68, 95% CI 0.61–0.76; I 2 = 0%), against multiple episodes was 29% (IRR 0.71, 95% CI 0.55–0.91; I 2 = 11.3%), and against severe malaria was 17–22% (RR 0.78–0.83). The R21 vaccine demonstrated 68% efficacy against first episodes (HR 0.32, 95% CI 0.26–0.39) and 67% against multiple episodes (IRR 0.33, 95% CI 0.27–0.41) in a single phase 3 trial. Pooled SAE incidence was 11.2% (95% CI 6.6–18.6%; I 2 = 96.2%) for RTS,S and 3% (95% CI 1–6%; I 2 = 80.6%) for R21, with no vaccine-attributable deaths. Both vaccines showed acceptable reactogenicity profiles. Conclusion: Both RTS,S and R21 vaccines demonstrate protective efficacy against clinical malaria in African children under five, with R21 showing higher efficacy in initial trials. RTS,S provides moderate, reproducible protection in clinical trials. Both vaccines have acceptable safety profiles, though continued pharmacovigilance is essential.

1 January 2025 in Annals of African Surgery
Verified
Journal Article
Open access
PDF file
MEMerna Akram Estreed
Merna Akram Estreed
JKJames Kigera
James Kigera